215 related articles for article (PubMed ID: 26492310)
21. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery.
Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM
JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794
[TBL] [Abstract][Full Text] [Related]
22. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
Bing S; Chen RR
Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous left atrial appendage occlusion: A South African experience.
Dippenaar AP; Saaiman JA; Brink PA; Heradien MJ; Van der Bijl P
S Afr Med J; 2022 Apr; 112(4):268-272. PubMed ID: 35587805
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis.
Jiang Y; Li F; Li D; Cheng Y; Jia Y; Fu H; Pu X; Hu H; Jiang J; Zeng R
Pacing Clin Electrophysiol; 2020 Jan; 43(1):123-132. PubMed ID: 31721242
[TBL] [Abstract][Full Text] [Related]
27. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
[TBL] [Abstract][Full Text] [Related]
30. An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion.
Yerasi C; Lazkani M; Kolluru P; Miryala V; Kim J; Moole H; Sawant AC; Morris M; Pershad A
J Interv Cardiol; 2018 Apr; 31(2):197-206. PubMed ID: 29495123
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the WATCHMAN left atrial appendage closure device.
Alli O; Holmes D
Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
[TBL] [Abstract][Full Text] [Related]
32. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA
JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182
[TBL] [Abstract][Full Text] [Related]
33. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
Raghuram P; Pavithran S; Sivakumar K
Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
[TBL] [Abstract][Full Text] [Related]
34. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
Onalan O; Crystal E
Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
[TBL] [Abstract][Full Text] [Related]
35. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
36. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD
Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152
[TBL] [Abstract][Full Text] [Related]
37. Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis.
Bode WD; Patel N; Gehi AK
J Interv Card Electrophysiol; 2015 Jun; 43(1):79-89. PubMed ID: 25711953
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.
Reddy VY; Akehurst RL; Armstrong SO; Amorosi SL; Brereton N; Hertz DS; Holmes DR
Europace; 2016 Jul; 18(7):979-86. PubMed ID: 26838691
[TBL] [Abstract][Full Text] [Related]
39. Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation.
Vrana E; Kartas A; Samaras A; Vasdeki D; Forozidou E; Liampas E; Karvounis H; Giannakoulas G; Tzikas A
J Cardiovasc Med (Hagerstown); 2022 Mar; 23(3):176-182. PubMed ID: 34580251
[TBL] [Abstract][Full Text] [Related]
40. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
